Skip to content

Bausch Health Companies BHC Additional Paid-In Capital

Additional Paid-In Capital at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%
Staar Surgical logo
Staar SurgicalSTAA
$507.92M+6.5%
Ardelyx logo
ArdelyxARDX
$1.13B+5.7%
Organon logo
OrganonOGN
$186M+43.1%
AbbVie logo
AbbVieABBV
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's additional paid-in capital?
Bausch Health Companies (BHC) reported additional paid-in capital of $295M in Q1 2026.
How has Bausch Health Companies's additional paid-in capital changed year-over-year?
Bausch Health Companies's additional paid-in capital increased by 34.1% year-over-year, from $220M to $295M.
What is the long-term trend for Bausch Health Companies's additional paid-in capital?
Over 5 years (2020 to 2025), Bausch Health Companies's additional paid-in capital has grown at a -4.7% compound annual growth rate (CAGR), from $454M to $357M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.